Status:
COMPLETED
Respiratory Physiology Under High Flow Therapy
Lead Sponsor:
Institut für Pneumologie Hagen Ambrock eV
Conditions:
Chronic Obstructive Pulmonary Disease
Eligibility:
All Genders
20-80 years
Phase:
NA
Brief Summary
The aim of this study is to gain knowledge about effects of high flow transnasal insufflation on various breathing parameters like intratracheal pressure conditions, CO2 elimination, breathing frequen...
Detailed Description
Ten patients, who are supplied with a tracheostomy stent (placeholder) for reinsertions after long term ventilation will be treated for a short time during the day with the nasal high flow system AIRV...
Eligibility Criteria
Inclusion
- Patients in a stable weaning phase after long term ventilation
- Patients supplied with tracheostomy stent (placeholder)
- Patients in stable respiratory situation
Exclusion
- Incapable of giving consent
- Any other severe or acute physical illness which requires intensive medical care
Key Trial Info
Start Date :
December 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2014
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT01509703
Start Date
December 1 2011
End Date
December 1 2014
Last Update
March 24 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Helios Klinik Hagen Ambrock
Hagen, North Rhine-Westphalia, Germany, 58091